Aurora Cannabis Inc. (TSE:ACB - Get Free Report) shares fell 0.8% during trading on Thursday . The stock traded as low as C$6.26 and last traded at C$6.34. 62,609 shares were traded during mid-day trading, a decline of 84% from the average session volume of 389,808 shares. The stock had previously closed at C$6.39.
Several research analysts have recently weighed in on ACB shares. TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. ATB Capital lowered their target price on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of C$5.85.
Get Our Latest Report on Aurora Cannabis
The company has a 50-day moving average of C$6.42 and a 200 day moving average of C$7.38. The company has a debt-to-equity ratio of 16.95, a current ratio of 3.76 and a quick ratio of 2.48. The company has a market cap of C$346.54 million, a PE ratio of -10.06 and a beta of 2.71.
Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.